Pharmacological characterization of six trkB antibodies reveals a novel class of functional agents for the study of the BDNF receptor

被引:31
作者
Cazorla, M. [1 ]
Arrang, J. M. [1 ]
Premont, J. [1 ]
机构
[1] Univ Paris 05, INSERM, Ctr Psychiat & Neurosci, Lab Neurobiol & Mol Pharmacol,UMR 894, Paris, France
关键词
BDNF; trkB receptor; functional ligand; agonist; antagonist; antibody; brain disease; cancer; NERVE GROWTH-FACTOR; TYROSINE KINASE; LOW-AFFINITY; NGF BINDING; NEUROTROPHINS; EXPRESSION; PATHOPHYSIOLOGY; METASTASIS; REQUIRES; ANOIKIS;
D O I
10.1111/j.1476-5381.2010.01094.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BACKGROUND AND PURPOSE By interacting with trkB receptors, brain-derived neurotrophic factor (BDNF) triggers various signalling pathways responsible for neurone survival, differentiation and modulation of synaptic transmission. Numerous reports have implicated BDNF and trkB in the pathogenesis of various central nervous system affections and in cancer, thus representing trkB as a promising therapeutic target. In this study, we used an antibody-based approach to search for trkB-selective functional reagents. EXPERIMENTAL APPROACH Six commercially available polyclonal and monoclonal antibodies were tested on recombinant and native, human and rodent trkB receptors. Functional and pharmacological characterization was performed using a modified version of the KIRA-elisa method and radioligand binding studies. Western blot analyses and neurite outgrowth assays were carried out to determine the specificity and selectivity of antibody effects. The survival properties of one antibody were further assessed on cultured neurones in a serum-deprived paradigm. KEY RESULTS The functional trkB-selective antibodies showed distinct pharmacological profiles, ranging from partial agonists to antagonists, acting on trkB receptors through allosteric modulations. The same diversity of effects was observed on the mitogen-activated protein kinase signalling pathway downstream of trkB and on the subsequent neurite outgrowth. One antibody with partial agonist activity demonstrated cell survival properties by activating the Akt pathway. Finally, these antibodies were functionally validated as true trkB-selective ligands because they failed activating trkA or trkC, and contrary to BDNF, none of them bind to p75NTR. CONCLUSIONS AND IMPLICATIONS These trkB-selective antibodies represent a novel class of pharmacological tools to explore the pathophysiological roles of trkB and its potential therapeutic relevance for the treatment of various disorders.
引用
收藏
页码:947 / 960
页数:14
相关论文
共 40 条
[1]  
Alexander SPH, 2009, BRIT J PHARMACOL, V158, pS1, DOI 10.1111/j.1476-5381.2009.00499.x
[2]   Specificity in Trk receptor:neurotrophin interactions:: The crystal structure of TrkB-d5 in complex with neurotrophin-4/5 [J].
Banfield, MJ ;
Naylor, RL ;
Robertson, AGS ;
Allen, SJ ;
Dawbarn, D ;
Brady, RL .
STRUCTURE, 2001, 9 (12) :1191-1199
[3]   DIFFERENTIAL EXPRESSION OF NERVE GROWTH-FACTOR RECEPTORS LEADS TO ALTERED BINDING-AFFINITY AND NEUROTROPHIN RESPONSIVENESS [J].
BENEDETTI, M ;
LEVI, A ;
CHAO, MV .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (16) :7859-7863
[4]  
Cattaneo A, 1999, J NEUROSCI, V19, P9687
[5]   Cyclotraxin-B, the First Highly Potent and Selective TrkB Inhibitor, Has Anxiolytic Properties in Mice [J].
Cazorla, Maxime ;
Jouvenceau, Anne ;
Rose, Christiane ;
Guilloux, Jean-Philippe ;
Pilon, Catherine ;
Dranovsky, Alex ;
Premont, Joel .
PLOS ONE, 2010, 5 (03)
[6]   Neurotrophins and their receptors: A convergence point for many signalling pathways [J].
Chao, MV .
NATURE REVIEWS NEUROSCIENCE, 2003, 4 (04) :299-309
[7]   P75 AND TRK - A 2-RECEPTOR SYSTEM [J].
CHAO, MV ;
HEMPSTEAD, BL .
TRENDS IN NEUROSCIENCES, 1995, 18 (07) :321-326
[8]   Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior [J].
Chen, Zhe-Yu ;
Jing, Deqiang ;
Bath, Kevin G. ;
Ieraci, Alessandro ;
Khan, Tanvir ;
Siao, Chia-Jen ;
Herrera, Daniel G. ;
Toth, Miklos ;
Yang, Chingwen ;
McEwen, Bruce S. ;
Hempstead, Barbara L. ;
Lee, Francis S. .
SCIENCE, 2006, 314 (5796) :140-143
[9]   TRKA CROSS-LINKING MIMICS NEURONAL RESPONSES TO NERVE GROWTH-FACTOR [J].
CLARY, DO ;
WESKAMP, G ;
AUSTIN, LR ;
REICHARDT, LF .
MOLECULAR BIOLOGY OF THE CELL, 1994, 5 (05) :549-563
[10]   The neurotrophic receptor TrkB: a drug target in anti-cancer therapy? [J].
Desmet, CJ ;
Peeper, DS .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2006, 63 (7-8) :755-759